Improvements in early cancer detection are key to increasing eligiblity for curative treatments and thereby reducing the incidence of cancer-related death. However, few screening tests exist for individuals with an average risk of cancer, and those that do exist focus on one cancer type, and are invasive and/or expensive. Liquid biopsy approaches hold promise in the non-invasive detection of cancer, but sensitivity is an issue. A new approach called CancerSEEK addresses many of these limtations and paves the way for a broadly applicable liquid biopsy screen for multiple cancer types.
14.09.2018 | Diagnostik in der Onkologie | International Research Highlight | Online-Artikel